𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck

✍ Scribed by Abhay S. Gokhale; Robert I. Haddad; Lisa A. Cavacini; Lori Wirth; Linda Weeks; Melissa Hallar; Jarrod Faucher; Marshall R. Posner


Book ID
113832449
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
269 KB
Volume
41
Category
Article
ISSN
1368-8375

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Vascular endothelial growth factor C and
✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 379 KB πŸ‘ 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph

Epidermal growth factor receptor targete
✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR